{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T02:33:05Z","timestamp":1726453985160},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Klin"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1007\/s00063-010-1105-8","type":"journal-article","created":{"date-parts":[[2010,9,27]],"date-time":"2010-09-27T05:47:14Z","timestamp":1285566434000},"page":"647-651","source":"Crossref","is-referenced-by-count":6,"title":["Prospektive Versorgungsforschungsstudie zur Therapie mit Immunglobulinen (SIGNS)"],"prefix":"10.1007","volume":"105","author":[{"given":"Wilhelm","family":"Kirch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralf","family":"Gold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manfred","family":"Hensel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Fa\u00dfhauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Pittrow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D\u00f6rte","family":"Huscher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcel","family":"Reiser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Stangel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrich","family":"Baumann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Borte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,9,28]]},"reference":[{"key":"1105_CR1","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.jaci.2007.08.053","volume":"120","author":"R.S. Geha","year":"2007","unstructured":"Geha RS, Notarangelo LD, Casanova JL, et al. Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee. J Allergy Clin Immunol 2007;120:776\u201394.","journal-title":"J Allergy Clin Immunol"},{"key":"1105_CR2","unstructured":"Hammarstr\u00f6m L. Pr\u00e4valenz, Screening und Diagnose von PIDs in der EU. In: European Primary Immunodeficiencies Consensus Conference: consensus report and recommendations, 2006:24\u20135 ( http:\/\/ec.europa.eu\/health\/ph_projects\/2005\/action1\/docs\/action1_2005_frep_01_de.pdf , Zugriff am 7. 6. 2010)."},{"key":"1105_CR3","volume-title":"Prim\u00e4re und sekund\u00e4re Immundefekte","year":"2009","unstructured":"Schmidt R, Baumann U, Hrsg. Prim\u00e4re und sekund\u00e4re Immundefekte, 2. Aufl. Bremen: Unimed, 2009.","edition":"2. Aufl."},{"key":"1105_CR4","unstructured":"Hallek M, Eichhorst B, Dreger P. DGHO-Leitlinie Chronische Lymphatische Leuk\u00e4mie. Stand 13. 12. 2006 ( http:\/\/www.dgho.de\/informationen\/leitlinien\/leukaemien\/Chronische%20lymphatische%20 Leukaemie.pdf , Zugriff am 7. 6. 2010)."},{"key":"1105_CR5","unstructured":"Einsele H, Naumann R, Goldschmidt H, et al. DGHO-Leitlinie Multiples Myelom. Stand Dezember 2009 ( http:\/\/www.dgho.de\/onkopedia\/Multiples%20Myelom , Zugriff am 7. 6. 2010)."},{"key":"1105_CR6","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0140-6736(95)90346-1","volume":"345","author":"A. Gardulf","year":"1995","unstructured":"Gardulf A, Andersen V, Bjorkander J, et al. Subcutaneous immunoglobulin replacement in patients with primary antibody deficiencies: safety and costs. Lancet 1995;345:365\u20139.","journal-title":"Lancet"},{"key":"1105_CR7","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1111\/j.1468-1331.2008.02246.x","volume":"15","author":"I. Elovaara","year":"2008","unstructured":"Elovaara I, Apostolski S, van Doorn P, et al. EFNS guidelines for the use of intravenous immunoglobulin in treatment of neurological diseases: EFNS Task Force on the Use of Intravenous Immunoglobulin in Treatment of Neurological Diseases. Eur J Neurol 2008;15:893\u2013908.","journal-title":"Eur J Neurol"},{"key":"1105_CR8","doi-asserted-by":"crossref","unstructured":"Stangel M, Gold R. Einsatz intraven\u00f6ser Immunglobuline in der Neurologie - ein evidenzbasierter Konsens: Update 2010. Nervenarzt:im Druck (Epub 2010 Jun 26).","DOI":"10.1007\/s00115-010-3059-8"},{"key":"1105_CR9","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2174\/157015909790031166","volume":"7","author":"S. Jacob","year":"2009","unstructured":"Jacob S, Rajabally YA. Current proposed mecha-nisms of action of intravenous immunoglobulins in inflammatory neuropathies. Curr Neuropharmacol 2009;7:337\u201342.","journal-title":"Curr Neuropharmacol"},{"key":"1105_CR10","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1468-1331.2009.02568.x","volume":"16","author":"T. Harbo","year":"2009","unstructured":"Harbo T, Andersen H, Hess A, et al. Subcutaneous versus intravenous immunoglobulin in multifocal motor neuropathy: a randomized, single-blinded cross-over trial. Eur J Neurol 2009;16:631\u20138.","journal-title":"Eur J Neurol"},{"key":"1105_CR11","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1007\/s00063-008-1100-5","volume":"103","author":"V. Knerr","year":"2008","unstructured":"Knerr V, Gathmann B, Eades-Perner AM, et al. [The ESID Online Database for primary immunodeficiencies. First analyses with regard to Germany and Europe.] Med Klin (Munich) 2008;103:620\u20137.","journal-title":"Med Klin (Munich)"},{"key":"1105_CR12","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1053\/euhj.2000.2265","volume":"21","author":"J.S. Alpert","year":"2000","unstructured":"Alpert JS. Are data from clinical registries of any value? Eur Heart J 2000;21:1399\u2013401.","journal-title":"Eur Heart J"},{"key":"1105_CR13","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1093\/eurheartj\/ehp596","volume":"31","author":"A.K. Gitt","year":"2010","unstructured":"Gitt AK, Bueno H, Danchin N, et al. The role of cardiac registries in evidence-based medicine. Eur Heart J 2010;31:525\u20139.","journal-title":"Eur Heart J"},{"key":"1105_CR14","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1055\/s-0029-1239516","volume":"71","author":"M. Koller","year":"2009","unstructured":"Koller M, Neugebauer EA, Augustin M, et al. [Assessment of quality of life in health services research \u2014 conceptual, methodological and structural prerequisites.] Gesundheitswesen 2009;71:864\u201372.","journal-title":"Gesundheitswesen"},{"key":"1105_CR15","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1477-7525-4-79","volume":"4","author":"FoodDrug Administration.","year":"2006","unstructured":"Food and Drug Administration. Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance. Health Qual Life Outcomes 2006;4:79 ( http:\/\/www.hqlo.com\/content\/pdf\/1477-7525-4-79.pdf , Zugriff am 2. 8. 2010.","journal-title":"Health Qual Life Outcomes"},{"key":"1105_CR16","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1111\/j.1524-4733.2005.00051.x","volume":"8","author":"A. Szende","year":"2005","unstructured":"Szende A, Leidy NK, Revicki D. Health-related quality of life and other patient-reported outcomes in the European centralized drug regulatory process: a review of guidance documents and performed authorizations of medicinal products 1995 to 2003. Value Health 2005;8:534\u201348.","journal-title":"Value Health"},{"key":"1105_CR17","unstructured":"Mapi Research Trust. Patient-reported Outcome and Quality of Life Instruments Database ( http:\/\/www.proqolid.org , Zugriff am 7. 6. 2010)."},{"key":"1105_CR18","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1007\/s00063-007-1092-6","volume":"102","author":"M. Bullinger","year":"2007","unstructured":"Bullinger M, Schmidt S, Petersen C, et al. [Methodological challenges and potentials of health-related quality of life evaluation in children with chronic health conditions under medical health care.] Med Klin (Munich) 2007;102:734\u201345.","journal-title":"Med Klin (Munich)"},{"key":"1105_CR19","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.2165\/00019053-200624120-00005","volume":"24","author":"U. Ravens-Sieberer","year":"2006","unstructured":"Ravens-Sieberer U, Erhart M, Wille N, et al. Generic health-related quality-of-life assessment in children and adolescents: methodological considerations. Pharmacoeconomics 2006;24:1199\u2013220.","journal-title":"Pharmacoeconomics"}],"container-title":["Medizinische Klinik"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00063-010-1105-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00063-010-1105-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00063-010-1105-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,5]],"date-time":"2019-06-05T02:55:50Z","timestamp":1559703350000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00063-010-1105-8"}},"subtitle":["Rationale, Design und Methodik"],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":19,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["1105"],"URL":"https:\/\/doi.org\/10.1007\/s00063-010-1105-8","relation":{},"ISSN":["0723-5003","1615-6722"],"issn-type":[{"value":"0723-5003","type":"print"},{"value":"1615-6722","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,9]]}}}